scispace - formally typeset
N

Norihiro Shibui

Researcher at Kyoto University

Publications -  6
Citations -  129

Norihiro Shibui is an academic researcher from Kyoto University. The author has contributed to research in topics: Dorsal raphe nucleus & Serotonergic. The author has an hindex of 5, co-authored 6 publications receiving 81 citations.

Papers
More filters
Journal ArticleDOI

Manipulation of dorsal raphe serotonergic neurons modulates active coping to inescapable stress and anxiety-related behaviors in mice and rats.

TL;DR: It is demonstrated that acute activation of serotonergic neurons in the dorsal raphe nucleus increases active coping with inescapable stress in rats and mice in a time-locked manner, and that acute inhibition of these neurons increases anxiety-like behaviors specifically in rats.
Journal ArticleDOI

Prediction of pharmacological activities from chemical structures with graph convolutional neural networks.

TL;DR: In this paper, a graph convolutional neural network (GCN) model was used to predict the activity of compounds from the ChEMBL database using two-dimensional structural information.
Journal ArticleDOI

Ketamine-Induced Prefrontal Serotonin Release Is Mediated by Cholinergic Neurons in the Pedunculopontine Tegmental Nucleus.

TL;DR: The results suggest the ketamine-induced serotonin release in medial prefrontal cortex is mediated by cholinergic neurons projecting from pedunculopontine tegmental nucleus to dorsal raphe nucleus via α4β2 nAChRs.
Journal ArticleDOI

Chronic antidepressant potentiates spontaneous activity of dorsal raphe serotonergic neurons by decreasing GABAB receptor-mediated inhibition of L-type calcium channels.

TL;DR: Chronic administration of an antidepressant, citalopram, disinhibited the serotonergic spontaneous firing activity by weakening the GABAB receptor-mediated inhibition of L-type VDCCs in Serotonergic neurons.
Journal ArticleDOI

A new designer drug 5F-ADB activates midbrain dopaminergic neurons but not serotonergic neurons.

TL;DR: The results suggest that 5F-ADB activates local CB1 receptors and potentiates midbrain dopaminergic systems with no direct effects on midbrain serotonergic systems.